Panagora Asset Management Inc Replimune Group, Inc. Transaction History

Panagora Asset Management Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	BUY	$5.01 - $9.46 $2,174 - $4,105	434 Added 0.77%	57,043 $513,000
Q1 2024 May 07, 2024	BUY	$6.87 - $9.31 $388,903 - $527,029	56,609 New	56,609 $462,000
Q2 2023 Aug 11, 2023	SELL	$15.65 - $24.1 $150,584 - $231,890	-9,622 Reduced 14.17%	58,268 $1.35 Million
Q1 2023 May 11, 2023	BUY	$17.48 - $29.09 $9,928 - $16,523	568 Added 0.84%	67,890 $1.2 Million
Q4 2022 Feb 13, 2023	SELL	$17.09 - $27.91 $991 - $1,618	-58 Reduced 0.09%	67,322 $1.83 Million
Q3 2022 Nov 14, 2022	SELL	$15.6 - $21.15 $1.63 Million - $2.21 Million	-104,259 Reduced 60.74%	67,380 $1.16 Million
Q2 2022 Aug 15, 2022	BUY	$13.32 - $19.98 $438,481 - $657,721	32,919 Added 23.73%	171,639 $3 Million
Q1 2022 May 12, 2022	BUY	$15.24 - $29.75 $231,175 - $451,277	15,169 Added 12.28%	138,720 $2.36 Million
Q4 2021 Feb 10, 2022	BUY	$25.43 - $34.25 $556,382 - $749,355	21,879 Added 21.52%	123,551 $3.35 Million
Q3 2021 Nov 10, 2021	BUY	$28.98 - $39.54 $466,983 - $637,147	16,114 Added 18.83%	101,672 $3.01 Million
Q2 2021 Aug 11, 2021	SELL	$28.5 - $39.37 $91,485 - $126,377	-3,210 Reduced 3.62%	85,558 $3.29 Million
Q1 2021 May 12, 2021	BUY	$30.22 - $45.57 $2.25 Million - $3.39 Million	74,366 Added 516.36%	88,768 $2.71 Million
Q4 2020 Feb 10, 2021	BUY	$23.5 - $52.65 $317,273 - $710,827	13,501 Added 1498.45%	14,402 $549,000
Q3 2020 Nov 13, 2020	BUY	$18.85 - $27.0 $16,983 - $24,327	901 New	901 $21,000

149

68M

52.3K

80.3K

Ticker REPL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,306,700
Market Cap $694M
Description
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.